Literature DB >> 29596972

A review of cluster randomized trials found statistical evidence of selection bias.

Jaime Bolzern1, Nandi Mnyama2, Katharine Bosanquet3, David J Torgerson3.   

Abstract

OBJECTIVES: To assess markers of selection bias risk in a sample of recently published cluster randomized controlled trials compared with individually randomized trials. STUDY DESIGN AND
SETTING: We used OVID Medline and the online archives of the Journal of the American Medical Association to search for cluster randomized trials published between January 2015 and June 2017 from four high-impact journals and compared them to a matched sample of individually randomized trials.
RESULTS: We identified 23 cluster trials: 57% (n = 13) described a robust allocation method and 17% (n = 4) recruited all participants before randomization. Four (17%), eight (35%), and 11 (48%) were classified as at low, medium, and high bias risk, respectively. Meta-analysis showed significant age imbalance (-0.05, 95% CI = -0.057 to -0.043, I2 = 93.2%) in cluster trials, while the matched individually randomized trials showed no imbalance (0.005, 95% CI = -0.026 to 0.035, I2 = 0%). Cluster trials finding a statistically significant outcome in their primary measure showed a larger age imbalance (0.082, 95% CI = -0.091 to -0.073, I2 = 87%) than trials finding a nonstatistically significant outcome (0.022, 95% CI = 0.008 to 0.035, I2 = 83%).
CONCLUSIONS: There is strong evidence in this sample of an effect of selection bias seen in an imbalance in baseline participant age, something not seen in a comparable sample of individually randomized trials.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Baseline characteristics; Cluster randomized controlled trials; Cluster trials; Meta-analysis; Randomized controlled trials; Selection bias

Mesh:

Year:  2018        PMID: 29596972     DOI: 10.1016/j.jclinepi.2018.03.010

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN: 0895-4356            Impact factor:   6.437


  5 in total

1.  Strategies to reduce the use of low-value medical tests in primary care: a systematic review.

Authors:  Toshihiko Takada; Pauline Heus; Sander van Doorn; Christiana A Naaktgeboren; Jan-Willem Weenink; Simone A van Dulmen; Lotty Hooft
Journal:  Br J Gen Pract       Date:  2020-11-26       Impact factor: 5.386

2.  Baseline testing in cluster randomised controlled trials: should this be done?

Authors:  Jaime E Bolzern; Alex Mitchell; David J Torgerson
Journal:  BMC Med Res Methodol       Date:  2019-05-17       Impact factor: 4.615

Review 3.  Successes and lessons learned in database development for national multi-site cancer care delivery research trials: the Alliance for Clinical Trials in Oncology experience.

Authors:  Sumithra J Mandrekar; Amylou C Dueck; David Zahrieh; Shauna L Hillman; Angelina D Tan; Jennifer L Frank; Travis Dockter; Bobbi Jo Meyers; Cassie L Cherevko; Elizabeth S Peil; Shaylene McCue; Oudom Kour; Heather J Gunn; Heather B Neuman; George J Chang; Electra D Paskett
Journal:  Trials       Date:  2022-08-09       Impact factor: 2.728

4.  Interim data monitoring in cluster randomised trials: Practical issues and a case study.

Authors:  K Hemming; J Martin; I Gallos; A Coomarasamy; L Middleton
Journal:  Clin Trials       Date:  2021-06-22       Impact factor: 2.486

5.  Characteristics and practices of school-based cluster randomised controlled trials for improving health outcomes in pupils in the United Kingdom: a methodological systematic review.

Authors:  Kitty Parker; Michael Nunns; ZhiMin Xiao; Tamsin Ford; Obioha C Ukoumunne
Journal:  BMC Med Res Methodol       Date:  2021-07-26       Impact factor: 4.615

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.